Bharat Biotech Has Again Applied for Emergency Authorisation of Covid-19 Vaccine, Say Sources

Posted on by

COVAXIN, an inactivated vaccine candidate, is currently undergoing Phase III human clinical trials on 26,000 volunteers at 25 centres across India, after having undergone Phase I and II trials involving 1,000 volunteers.